Showing results (211-220 of 931) with videos related to
Sort By:
Pageof 94
American Journal of Hematology|May 23, 2013
Recent advances in de novo CD5+ diffuse large B cell lymphomaPreetesh Jain, Luis E Fayad, Andreas Rosenwald, et al.Cancer|January 20, 2011
Experience with rituximab immunotherapy as an early intervention in patients with Rai stage 0 to II chronic lymphocytic leukemiaAlessandra Ferrajoli, Michael J Keating, Susan O'Brien, et al.JAMA Oncology|September 1, 2017
Salvage Chemoimmunotherapy With Inotuzumab Ozogamicin Combined With Mini-Hyper-CVD for Patients With Relapsed or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: A Phase 2 Clinical TrialElias Jabbour, Farhad Ravandi, Partow Kebriaei, et al.Blood Advances|September 15, 2021
Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experienceGuillaume Richard-Carpentier, Hagop M Kantarjian, Guilin Tang, et al.Journal of the American Chemical Society|November 13, 2012
Temperature-dependent dynamical transitions of different classes of amino acid residue in a globular proteinYinglong Miao, Zheng Yi, Dennis C Glass, et al.Clinical Lymphoma, Myeloma & Leukemia|July 7, 2024
Efficacy of Chemotherapy-Free Regimens in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Systematic Review and Meta-AnalysisMuhammad Ashar Ali, Wajeeha Aiman, Hagop Kantarjian, et al.Pain Medicine (Malden, Mass.)|November 26, 2024
Pressure pain sensitivity is independent of structural pathology in patients with subacromial pain syndrome: a cross-sectional analysisChris Pierson, Richard Wilson, Karen Brewer-Mixon, et al.American Journal of Hematology|November 5, 2019
The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survivalMusa Yilmaz, Hagop Kantarjian, Xuemei Wang, et al.Plos One|February 8, 2014
In vivo genotoxicity assessment of titanium dioxide nanoparticles by Allium cepa root tip assay at high exposure concentrationsSunandan Pakrashi, Nitin Jain, Swayamprava Dalai, et al.Leukemia Research|November 18, 2008
Imatinib has limited therapeutic activity for hypereosinophilic syndrome patients with unknown or negative PDGFRalpha mutation statusNitin Jain, Jorge Cortes, Alfonso Quintás-Cardama, et al.Pageof 94